Study guide

4.11 Health Literacy, Informed Consent & Informed Decision Making

Certified Genetic Counselor CGC

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the CGC Exam & Credential 1.2 Eligibility Categories, Application & Fees 1.3 Scoring, Pass Rate & Test-Day Logistics

2 Domain 1A: Clinical Information

1.4 Medical & Pregnancy History 1.5 Teratogens, Exposures & Non-Genetic Risk Factors 1.6 Differential Diagnosis, Indication & Referral Urgency 1.7 Referral Triage, Case Preparation & Records Review

3 Domain 1B: Human Development

1.8 Fetal Development 1.9 Developmental Milestones 1.10 Physical & Psychological Development

4 Domain 1C: Chromosomal & Contiguous Gene Syndromes

1.11 Aneuploidy Syndromes (Down, Turner, Klinefelter, Edwards, Patau) 1.12 Microdeletion Syndromes (22q11.2, Williams, and Related) 1.13 Imprinting Disorders (PWS, Angelman, Beckwith-Wiedemann, Russell-Silver)

5 Domain 1C: Hereditary Cancer Syndromes

1.14 Hereditary Breast & Ovarian Cancer (BRCA1/2, PALB2, and Related) 1.15 Lynch Syndrome & Polyposis Syndromes 1.16 Li-Fraumeni, VHL, MEN, NF1/NF2 & Other Cancer Predisposition

6 Domain 1C: Metabolic, Neuromuscular & Multisystem Conditions

1.17 Inborn Errors of Metabolism & Storage Disorders 1.18 Neuromuscular Disease & Fragile X Spectrum 1.19 Connective Tissue & Cardiovascular Genetics 1.20 Screening, Surveillance, Treatment & Diagnostic Strategy Framework

7 Domain 2A: Pedigree & Risk Assessment

2.1 Family History, Pedigree Construction & Analysis 2.2 Mendelian Risk Calculations 2.3 Bayesian Risk Calculations 2.4 Empiric Risk, Multifactorial Recurrence & Risk-Assessment Models 2.5 Residual Risk & Follow-Up Medical Plans

8 Domain 2B: Inheritance Principles

2.6 Mendelian Inheritance Patterns 2.7 Non-Mendelian Inheritance (Mitochondrial, Imprinting, Multifactorial) 2.8 Penetrance, Expressivity, Anticipation & Heterogeneity 2.9 Mosaicism, X-Inactivation & Epigenetic Modifiers of Phenotype

9 Domain 2B: Population Genetics & Variation

2.10 Population Genetics, HWE & Quantitative Genetics 2.11 Human Genetic Variation & Disease Susceptibility

10 Domain 3A: Test Methodologies

3.1 Karyotype, FISH & Chromosomal Microarray 3.2 Molecular Diagnostics (Sanger, NGS Panels, WES, WGS, MLPA) 3.3 Sample Types, Clinical Context & Predictive Metrics

11 Domain 3A: Variant Interpretation

3.4 ACMG/AMP Variant Classification 3.5 Reanalysis, Reclassification & Validity/Utility Framework

12 Domain 3B: Testing Options

3.6 Diagnostic Testing Strategies 3.7 Screening Testing (including Newborn Screening) 3.8 Predictive & Pre-symptomatic Testing 3.9 Carrier, Somatic & Research Testing

13 Domain 3C: Reproductive Risk Management

3.10 Assisted Reproductive Technologies & PGT 3.11 Family Planning & Reproductive Options 3.12 Prenatal Screening (NIPT, Serum Markers) 3.13 Prenatal Diagnostic Procedures (CVS, Amniocentesis)

14 Domain 4A: Counseling Foundations

4.1 Contracting & Interviewing Techniques 4.2 Psychosocial Assessment, Follow-Up & Family Dynamics 4.3 Client Personal Identity & Cultural Humility

15 Domain 4A: Theories, Coping & Dynamics

4.4 Counseling Theories & Models (REM, Trajectory) 4.5 Defense Mechanisms, Coping & Decision-Making Styles 4.6 Grief, Perinatal Loss & Crisis Response 4.7 Self-Awareness & Client-Counselor Dynamics

16 Domain 4B: Communication & Education

4.8 Delivery Modes & Working with Interpreters 4.9 Risk Communication Theories & Models 4.10 Results Delivery & Long-Term Follow-Up 4.11 Health Literacy, Informed Consent & Informed Decision Making

17 Domain 5A–B: Finance & Client Resources

5.1 Insurance Policies, Billing & Letters of Medical Necessity 5.2 Billing, Coding & Reimbursement Compliance 5.3 Client Resources, Appropriateness & Timely Delivery

18 Domain 5C: Legal & Regulatory Requirements

5.4 GINA & Genetic Non-Discrimination Legislation 5.5 Privacy, Confidentiality, Documentation & Genomic Data Security 5.6 Human-Subjects Research Standards & Patient Access to Information 5.7 CLIA, Laboratory-Developed Tests & FDA Oversight 5.8 Genomic Data Security, DTC Testing & Data Sharing

19 Domain 5D: Professional Frameworks

5.9 NSGC Code of Ethics & Ethical Decision Making 5.10 Scope of Practice, Clinical Supervision & Conflict of Interest 5.11 Licensure, Credentialing & Maintaining the CGC Credential 5.12 Evidence-Based Practice & Professional/Public Education

20 Integration & Exam Strategy

6.1 Integrating Domains in Case-Based Practice & Exam Strategy

4.11 Health Literacy, Informed Consent & Informed Decision Making

Key Takeaways Explain This Topic AI

Health literacy assessment is ongoing and observational (teach-back, form navigation, question quality)—not a one-time quiz that stereotypes education level.

Informed consent for genetic testing requires understanding of purpose, procedures, benefits, risks/limitations (including uncertain results and privacy implications), alternatives, and voluntariness—documented as a process, not a signature alone.

Informed decision-making emphasizes values-congruent choice under uncertainty; shared decision-making collaboratively weighs options while respecting that classic non-directiveness remains influential in genetic counseling identity.

Non-directiveness does not mean abandoning expertise, structure, or recommendations for medical management after a pathogenic result; it means resisting coercive steering of personal reproductive or testing choices.

Exam stems often distinguish authentic consent/decision support from hurried signature collection or covertly directive framing.

Last updated: August 2026

Why literacy and consent sit at the heart of Domain 4B

Communication fails quietly when materials assume college-level numeracy, when consent is reduced to a scrolled e-signature, or when “non-directive” is misunderstood as withholding necessary recommendations. ABGC expects genetic counselors to assess health literacy , obtain informed consent appropriate to genetic testing, and facilitate informed decision-making —including navigating the historic tension with non-directiveness and modern shared decision-making .

Health literacy in genetic counseling

Health literacy is the capacity to obtain, process, and understand health information to make decisions. Genetics adds vocabulary load (penetrance, mosaicism, VUS), numeracy demands, and family-systems complexity.

Assessment approach What you notice Adaptation

Teach-back Client cannot restate residual risk or purpose of test Simplify language; use frequencies; repeat with visuals

Form navigation Difficulty with portals, insurance forms, consents Read aloud key sections; teach-back each element; advocate for plain-language forms

Question quality Only yes/no answers; nods without questions after dense teaching Pause more; ask “What part should we go over again?”

Language / literacy mismatch Prefers oral information; limited reading in any language Oral + pictorial aids; avoid relying on long English PDFs

  • Digital literacy Cannot use telehealth tools Phone alternative; in-person; caregiver support with permission
  • Do not equate education or profession with literacy

Physicians, engineers, and teachers can still struggle with probabilistic genetics. Conversely, clients with less formal schooling may have strong experiential health knowledge. Assess performance in the session , not demographics. Shame (“This is simple”) destroys rapport.

Plain-language habits

Prefer “chance” or “risk out of 100” over stacked conditionals when possible.

Define terms once, then reuse the same plain phrase.

Chunk: purpose → procedure → possible results → next steps.

Limit new concepts per block; check in frequently.

Informed consent for genetic testing

Consent is a process culminating in an authorized decision, not the PDF alone. Elements typically addressed in genetic testing contexts:

  • Element Genetics-specific content
  • Purpose / indication Why this test for this person now
  • Description of test Sample type; scope (single site, panel, exome); what it can/cannot detect
  • Benefits Diagnose, refine risk, guide management, inform relatives when applicable

Risks / harms Anxiety; ambiguous results; incidental/secondary findings (as applicable); privacy/discrimination concerns (contextualize GINA limits); family tension; rare physical risks of procedures (CVS/amnio)

  • Limitations Sensitivity gaps; VUS; negative ≠ no risk; variants of uncertain clinical utility
  • Alternatives Different test, defer testing, decline testing, empiric management without molecular confirmation
  • Voluntariness Freedom from coercion by clinicians or family; right to refuse or stop
  • Privacy / data Who receives results; laboratory practices at a high level; research opt-ins if separate
  • Opportunity for questions Adequate time; interpreter if needed

For predictive/pre-symptomatic testing (e.g., Huntington disease protocols historically), psychosocial readiness and timing may be part of institutional pathways—boards still reward assessing understanding and pressure, even when exact protocol details vary.

Consent vs assent vs family pressure

Adults consent for themselves. Minors: parental permission + child assent developmentally as appropriate; adolescent autonomy issues appear in testing-for-adult-onset conditions debates (often ethics-heavy). When a partner demands testing “or else,” assess coercion; delay decision-making rather than treating a coerced signature as valid informed consent.

Informed decision-making and shared decision-making

Informed decision-making means the client understands relevant options/outcomes well enough to choose consistently with their values—including choosing not to test.

Shared decision-making (SDM) is a collaborative process: clinician brings evidence and structure; client brings values/preferences; together they deliberate. Decision aids, option grids, and explicit value clarifications support SDM.

Approach Counselor stance Risk if misunderstood

Classic non-directiveness Facilitate autonomy; avoid steering reproductive/testing choices toward counselor values Becoming passive, withholding expertise, or refusing to recommend medically indicated surveillance

Shared decision-making Partner on deliberating options with evidence Covertly directing while calling it “sharing”; or overwhelming with options without guidance

Directive medical recommendation Appropriate for many management actions after diagnosis (e.g., guideline-based MRI) Using “recommendation” to coerce reproductive choices

Teaching the tension carefully (exam + clinic)

Genetic counseling’s non-directive tradition grew from reproductive counseling history—resisting eugenic pressure and counselor-imposed choices about pregnancy and testing. That ethos still matters: do not push amniocentesis, termination, or predictive testing to satisfy your anxiety or institutional throughput.

Non-directiveness is not :

Refusing to correct misinformation.

Withholding professional recommendations for evidence-based medical management.

Having no session structure or agenda.

Pretending all options are equal when risks differ dramatically and the client asks for a recommendation framed as clinical judgment.

SDM can honor autonomy and expertise: “Based on this pathogenic variant and guidelines, I recommend high-risk breast surveillance; whether to pursue risk-reducing surgery is a preference-sensitive decision we can walk through together.” That sentence is not a contradiction—it separates strong clinical recommendation from value-laden preference-sensitive choice .

On boards, distractors often:

Equate non-directive with “never recommend anything.”

Treat consent as signature-only.

Use scare framing that is covertly directive (“Anyone who cares about their kids would test”).

  • Ignore literacy barriers and blame the client for “noncompliance.”
  • Scenario patterns

Scenario — low literacy, complex panel: Client nods through a 20-gene lecture. Best move: stop, use teach-back, simplify to decision-relevant chunks, offer return visit—do not proceed to draw based on nodding alone.

Scenario — partner coercion: Client whispers they do not want testing; partner answers all questions. Separate conversation if safe; affirm voluntariness; defer testing.

Scenario — “Just tell me what to do” about amniocentesis: Explore values, provide balanced outcomes, and if they still want a recommendation, offer a transparent clinical recommendation plus affirmation that declining remains acceptable—document the process.

Scenario — pathogenic result management: Non-directive reproductive counseling ≠ declining to recommend guideline-indicated cardiac screening for a pathogenic cardiomyopathy variant.

Common traps

Signature without understanding.

Assuming literacy from appearance or job.

Covert direction via selective framing of risks only.

Misdefining non-directiveness as clinical abandonment.

  • Skipping interpreter/plain language and calling consent “informed.”
  • Quick exam checklist

Was literacy assessed with teach-back or equivalent?

Were purpose, benefits, risks, limitations, alternatives, and voluntariness covered?

Is the choice values-congruent and free from coercion?

Did I distinguish preference-sensitive decisions from medically indicated recommendations?